Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery: An Overview of Noteworthy Case Studies, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) January 06, 2022 -- Measurements of changes in gene activation and expression provide a basis to understand genetic changes that cause

Related Keywords

United Kingdom ,Paul Diehl ,Honeycomb Worldwide Inc ,Cellecta Inc ,Chief Operating Officer ,Scalable Genetic Screens ,Novel Therapeutic Target Discovery ,Noteworthy Case ,Life Science ,Press Release ,